Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q41615778)
Watch
English
The potential for immunoconjugates in lymphoma therapy.
scientific article published on October 1997
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9336727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9336727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
The potential for immunoconjugates in lymphoma therapy
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9336727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9336727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
author
Oliver W Press
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9336727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9336727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
author name string
S Y Liu
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9336727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9336727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
language of work or name
English
1 reference
based on heuristic
inferred from title
publication date
1 October 1997
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9336727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9336727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
published in
Hematology / Oncology Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9336727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9336727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
volume
11
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9336727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9336727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
issue
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9336727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9336727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
page(s)
987-1006
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9336727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9336727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
cites work
Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase 1a clinical trial of LYM-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replacing the complementarity-determining regions in a human antibody with those from a mouse
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radioimmunotherapy of lymphoma: a UC Davis experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reshaping human antibodies for therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting of cytotoxic cells with heterocrosslinked antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Redesigning nature's poisons to create anti-tumor reagents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970475-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0889-8588(05)70475-5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9336727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9336727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
PubMed publication ID
9336727
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9336727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9336727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit